Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sami Suilamo

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2013
Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy menAnne Roivainen, Esa Kähkönen, Pauliina Luoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2014
¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy menPauliina Luoto, Sami Suilamo, Vesa Oikonen, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 18, 2012
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patientsLilie L Lin, Antti Silvoniemi, James B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2020
First-in-Humans Study of <sup>68</sup>Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1Riikka Viitanen, Olli Moisio, Petteri Lankinen, et al.
Acta Oncologica (Stockholm, Sweden)|May 18, 2026
KaSARi: a national framework for standardized, automated, and predictive radiotherapy in FinlandJan Seppälä, Maria Tengström, Henri Korkalainen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2013
Plasma pharmacokinetics, whole-body distribution, metabolism, and radiation dosimetry of 68Ga bombesin antagonist BAY 86-7548 in healthy menAnne Roivainen, Esa Kähkönen, Pauliina Luoto, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 20, 2014
¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy menPauliina Luoto, Sami Suilamo, Vesa Oikonen, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 18, 2012
Radiation dosimetry and biodistribution of the hypoxia tracer (18)F-EF5 in oncologic patientsLilie L Lin, Antti Silvoniemi, James B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2020
First-in-Humans Study of <sup>68</sup>Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1Riikka Viitanen, Olli Moisio, Petteri Lankinen, et al.
Acta Oncologica (Stockholm, Sweden)|May 18, 2026
KaSARi: a national framework for standardized, automated, and predictive radiotherapy in FinlandJan Seppälä, Maria Tengström, Henri Korkalainen, et al.
Pageof 3